je.st
news
Tag: therapeutics
Marina Biotech Announces That Licensee Mirna Therapeutics Reported Initiation Of A Phase 1 Clinical Trial Of Anticancer Drug MRX34
2013-06-05 06:56:06| drugdiscoveryonline News Articles
Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the Company's licensee, Mirna Therapeutics, has reported that they have initiated a Phase 1 clinical study of MRX34, the first miRNA to advance into a human clinical trial for cancer
Tags: reported
trial
drug
phase
Leader in Pain Therapeutics Chooses PAS-X PROCESS DEVELOPMENT
2013-05-29 06:00:00| Industrial Newsroom - All News for Today
Werum's software product ensures transparent management of starting materials in pharmaceuticals development at Grünenthal, Germany<br /> <br /> Lueneburg, Germany - The research-based international pharmaceutical company Grünenthal will deploy the PAS-X PROCESS DEVELOPMENT package. The group is leading in the field of pain therapies and invests more than a quarter of its revenues in research and development. Operating Werum's PAS-X PROCESS DEVELOPMENT, pharmaceutical and biotech companies can ...This story is related to the following:Manufacturing Execution Systems | Warehouse Management Software |
Tags: development
process
leader
pain
Esperion Therapeutics seeking $70 million in IPO filing
2013-05-17 16:13:24| Biotech - Topix.net
In documents filed Tuesday with the U.S. Securities and Exchange Commission , the company declared that it is setting a $70 million goal for the initial public offering and will be traded on the Nasdaq Stock Market under the symbol ESPR .
Tags: million
filing
seeking
ipo
Transition Therapeutics says diabetes drug shows positive results
2013-04-30 20:21:11| Biotech - Topix.net
ROB Insight is The Globe and Mail's exclusive feature led by a team of award-winning editors and writers who provide you with in-depth analysis on breaking business news and the issues that matter most.
Tags: results
shows
positive
drug
Acorda Therapeutics rises on Ampyra study Shares of Acorda...
2013-04-16 13:01:21| Biotech - Topix.net
Inc. jumped Monday after the company said that its drug Ampyra helped stroke patients recover their ability to walk in a mid-stage clinical trial.
Tags: study
shares
rises
therapeutics
Sites : [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] next »